pLenti6/UbC/mSlc7a1 Citations (24)
Originally described in: Induction of pluripotent stem cells from adult human fibroblasts by defined factors.Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S Cell. 2007 Nov 30. 131(5):861-72. PubMed Journal
Articles Citing pLenti6/UbC/mSlc7a1
| Articles |
|---|
| EOS lentiviral vector selection system for human induced pluripotent stem cells. Hotta A, Cheung AY, Farra N, Garcha K, Chang WY, Pasceri P, Stanford WL, Ellis J. Nat Protoc. 2009 . 4(12):1828-44. PubMed |
| Activin a plays a critical role in proliferation and differentiation of human adipose progenitors. Zaragosi LE, Wdziekonski B, Villageois P, Keophiphath M, Maumus M, Tchkonia T, Bourlier V, Mohsen-Kanson T, Ladoux A, Elabd C, Scheideler M, Trajanoski Z, Takashima Y, Amri EZ, Lacasa D, Sengenes C, Ailhaud G, Clement K, Bouloumie A, Kirkland JL, Dani C. Diabetes. 2010 Oct;59(10):2513-21. doi: 10.2337/db10-0013. Epub 2010 Jun 8. PubMed |
| Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives. Yehezkel S, Rebibo-Sabbah A, Segev Y, Tzukerman M, Shaked R, Huber I, Gepstein L, Skorecki K, Selig S. Epigenetics. 2011 Jan;6(1):63-75. doi: 10.4161/epi.6.1.13390. Epub 2011 Jan 1. PubMed |
| The generation and the manipulation of human multipotent adipose-derived stem cells. Wdziekonski B, Mohsen-Kanson T, Villageois P, Dani C. Methods Mol Biol. 2011;702:419-27. doi: 10.1007/978-1-61737-960-4_30. PubMed |
| Transduction of human cells with polymer-complexed ecotropic lentivirus for enhanced biosafety. Barrilleaux B, Knoepfler P. J Vis Exp. 2011 Jul 24;(53). pii: 2822. doi: 10.3791/2822. PubMed |
| Modeling sarcomagenesis using multipotent mesenchymal stem cells. Rodriguez R, Rubio R, Menendez P. Cell Res. 2012 Jan;22(1):62-77. doi: 10.1038/cr.2011.157. Epub 2011 Sep 20. PubMed |
| Derivation of induced pluripotent stem cells by retroviral gene transduction in mammalian species. Imamura M, Okuno H, Tomioka I, Kawamura Y, Lin ZY, Nakajima R, Akamatsu W, Okano HJ, Matsuzaki Y, Sasaki E, Okano H. Methods Mol Biol. 2012;925:21-48. doi: 10.1007/978-1-62703-011-3_2. PubMed |
| Reversal of aberrant cancer methylome and transcriptome upon direct reprogramming of lung cancer cells. Mahalingam D, Kong CM, Lai J, Tay LL, Yang H, Wang X. Sci Rep. 2012;2:592. doi: 10.1038/srep00592. Epub 2012 Aug 21. PubMed |
| A quantitative signaling screen identifies CARD11 mutations in the CARD and LATCH domains that induce Bcl10 ubiquitination and human lymphoma cell survival. Chan W, Schaffer TB, Pomerantz JL. Mol Cell Biol. 2013 Jan;33(2):429-43. doi: 10.1128/MCB.00850-12. Epub 2012 Nov 12. PubMed |
Direct induction of chondrogenic cells from human dermal fibroblast culture by defined factors.
Outani H, Okada M, Yamashita A, Nakagawa K, Yoshikawa H, Tsumaki N.
PLoS One. 2013 Oct 16;8(10):e77365. doi: 10.1371/journal.pone.0077365. eCollection 2013.
PubMed
Associated Plasmids |
| Differentiation of human induced pluripotent stem cells into brown and white adipocytes: role of Pax3. Mohsen-Kanson T, Hafner AL, Wdziekonski B, Takashima Y, Villageois P, Carriere A, Svensson M, Bagnis C, Chignon-Sicard B, Svensson PA, Casteilla L, Smith A, Dani C. Stem Cells. 2014 Jun;32(6):1459-67. doi: 10.1002/stem.1607. PubMed |
| Human fucci pancreatic Beta cell lines: new tools to study Beta cell cycle and terminal differentiation. Carlier G, Maugein A, Cordier C, Pechberty S, Garfa-Traore M, Martin P, Scharfmann R, Albagli O. PLoS One. 2014 Sep 26;9(9):e108202. doi: 10.1371/journal.pone.0108202. eCollection 2014. PubMed |
| Reprogramming fibroblasts toward cardiomyocytes, neural stem cells and hepatocytes by cell activation and signaling-directed lineage conversion. Zhu S, Wang H, Ding S. Nat Protoc. 2015 Jul;10(7):959-73. doi: 10.1038/nprot.2015.059. Epub 2015 Jun 4. PubMed |
| Systematic evaluation of markers used for the identification of human induced pluripotent stem cells. Bharathan SP, Manian KV, Aalam SM, Palani D, Deshpande PA, Pratheesh MD, Srivastava A, Velayudhan SR. Biol Open. 2017 Jan 15;6(1):100-108. doi: 10.1242/bio.022111. PubMed |
| PKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell Growth. Morita M, Sato T, Nomura M, Sakamoto Y, Inoue Y, Tanaka R, Ito S, Kurosawa K, Yamaguchi K, Sugiura Y, Takizaki H, Yamashita Y, Katakura R, Sato I, Kawai M, Okada Y, Watanabe H, Kondoh G, Matsumoto S, Kishimoto A, Obata M, Matsumoto M, Fukuhara T, Motohashi H, Suematsu M, Komatsu M, Nakayama KI, Watanabe T, Soga T, Shima H, Maemondo M, Tanuma N. Cancer Cell. 2018 Mar 12;33(3):355-367.e7. doi: 10.1016/j.ccell.2018.02.004. PubMed |
| Conversion of human and mouse fibroblasts into lung-like epithelial cells. Wong AP, Shojaie S, Liang Q, Xia S, Di Paola M, Ahmadi S, Bilodeau C, Garner J, Post M, Duchesneau P, Waddell TK, Bear CE, Nagy A, Rossant J. Sci Rep. 2019 Jun 21;9(1):9027. doi: 10.1038/s41598-019-45195-y. PubMed |
| SNAIL- and SLUG-induced side population phenotype of HCT116 human colorectal cancer cells and its regulation by BET inhibitors. Kato Y, Kondo S, Itakura T, Tokunaga M, Hatayama S, Katayama K, Sugimoto Y. Biochem Biophys Res Commun. 2020 Jan 1;521(1):152-157. doi: 10.1016/j.bbrc.2019.10.094. Epub 2019 Oct 22. PubMed |
| Template Activating Factor-I alpha Regulates Retroviral Silencing during Reprogramming. Bui PL, Nishimura K, Seminario Mondejar G, Kumar A, Aizawa S, Murano K, Nagata K, Hayashi Y, Fukuda A, Onuma Y, Ito Y, Nakanishi M, Hisatake K. Cell Rep. 2019 Nov 12;29(7):1909-1922.e5. doi: 10.1016/j.celrep.2019.10.010. PubMed |
| Generation of Rat Monoclonal Antibodies Specific for Human Stromal Cell-Derived Factor-2. Tanaka M, Shiota M, Koyama M, Nakayama J, Yashiro M, Semba K, Goda N. Monoclon Antib Immunodiagn Immunother. 2020 Feb;39(1):23-26. doi: 10.1089/mab.2019.0043. Epub 2020 Jan 9. PubMed |
| Reprogramming competence of OCT factors is determined by transactivation domains. Kim KP, Wu Y, Yoon J, Adachi K, Wu G, Velychko S, MacCarthy CM, Shin B, Ropke A, Arauzo-Bravo MJ, Stehling M, Han DW, Gao Y, Kim J, Gao S, Scholer HR. Sci Adv. 2020 Sep 2;6(36). pii: 6/36/eaaz7364. doi: 10.1126/sciadv.aaz7364. Print 2020 Sep. PubMed |
| Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia. Ecker V, Stumpf M, Brandmeier L, Neumayer T, Pfeuffer L, Engleitner T, Ringshausen I, Nelson N, Jucker M, Wanninger S, Zenz T, Wendtner C, Manske K, Steiger K, Rad R, Muschen M, Ruland J, Buchner M. Nat Commun. 2021 Jun 10;12(1):3526. doi: 10.1038/s41467-021-23752-2. PubMed |
| Regulation of CCR4-NOT complex deadenylase activity and cellular responses by MK2-dependent phosphorylation of CNOT2. Suzuki T, Hoshina M, Nishijima S, Hoshina N, Kikuguchi C, Tomohiro T, Fukao A, Fujiwara T, Yamamoto T. RNA Biol. 2022;19(1):234-246. doi: 10.1080/15476286.2021.2021676. Epub 2021 Dec 31. PubMed |
| Generation, characterization, and differentiation of induced pluripotent stem-like cells in the domestic cat. Kanegi R, Hatoya S, Kimura K, Yodoe K, Nishimura T, Sugiura K, Kawate N, Inaba T. J Reprod Dev. 2023 Dec 8;69(6):317-327. doi: 10.1262/jrd.2022-038. Epub 2023 Oct 26. PubMed |
| Antigen experience history directs distinct functional states of CD8+ CAR T cells during the anti-leukemia response. DeGolier KR, Danis E, D'Antonio M, Cimons J, Yarnell M, Kedl RM, Kohler ME, Scott-Browne JP, Fry TJ. Res Sq [Preprint]. 2023 Dec 21:rs.3.rs-3712137. doi: 10.21203/rs.3.rs-3712137/v1. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.